logo

Exhibiting at VIV Asia 2025

1-1870
Bangkok
12 Mar - 14 Mar, 2025

Product Offerings

Products:

Artificial Insemination Equipment: Semen collection, analysis, and insemination tools for various animal species

Embryo Transfer Solutions: Devices and media for efficient embryo handling and transfer

Cryopreservation Equipment: Systems and consumables for semen and embryo freezing and storage

Veterinary Imaging: Ultrasound machines and imaging solutions for reproductive health monitoring

IMV Technologies, headquartered in L'Aigle, France, is a world-leading innovator in animal and human reproductive biotechnologies. Established in 1963, the company has played a pioneering role in developing advanced solutions for artificial insemination (AI), embryo transfer, cryopreservation, and reproductive health monitoring. With operations in more than 120 countries, IMV Technologies supports both livestock breeding programs and clinical applications in human fertility, offering comprehensive solutions grounded in decades of scientific excellence.

The company operates under multiple specialized brands, including Cryo Bio System (CBS) for human and laboratory cryobiology, and maintains strong collaborations with veterinary, agricultural, and medical institutions worldwide. IMV Technologies is a cornerstone for the optimization of genetic dissemination and reproductive performance across species.

Core Business

IMV Technologies specializes in integrated reproductive technologies that support semen and embryo management, insemination, diagnostic imaging, and fertility enhancement. Its diverse business units include:

  • Animal Reproduction Technologies – for cattle, swine, sheep, goats, horses, and poultry
  • Human Assisted Reproductive Technologies (ART) – under the Cryo Bio System brand
  • Veterinary Imaging and Diagnostics
  • Cryopreservation and Biobank Solutions

Their innovations help improve reproduction efficiency, genetic progress, disease control, and sustainability in animal agriculture and human medicine.

Product and Service Offerings

Animal Reproduction Solutions

  • Artificial Insemination (AI) Equipment
    • Semen collection kits, extenders, filling and sealing machines
    • Insemination pipettes, sheaths, and applicators
  • Embryo Transfer Systems
    • Catheters, straws, vitrification media
  • Cryopreservation Equipment
    • Liquid nitrogen containers, programmable freezers, CBS High Security™ straws
  • Veterinary Ultrasound Imaging
    • Reproductive scanners for livestock and equine professionals

Human Fertility Solutions (via Cryo Bio System)

  • High-security storage devices for oocytes, embryos, and semen
  • Cryo Bio vitrification kits and straws
  • IVF lab consumables and identification solutions

Their solutions are tailored to various livestock systems, research institutions, semen centers, veterinary clinics, and human fertility labs.

Specialisation and Core USP

IMV Technologies stands out for its deep specialization in reproductive biology and biotechnological innovation. Key differentiators include:

  • 60+ years of expertise in semen and embryo technology
  • Patented high-security straws (CBS™) for ultra-safe cryopreservation
  • Integrated imaging and insemination tools, ensuring precision and ease-of-use
  • Global leadership in AI consumables and semen preservation systems
  • Multispecies coverage, with protocols and kits customized per animal type

The company is especially known for enabling genetic traceability, biosecurity, and reproductive efficiency, essential for high-value breeding programs and conservation.

Financials

While IMV Technologies is privately held and does not disclose public financials, it operates as a part of the IMV Group, which includes subsidiaries across Europe, the Americas, and Asia. Key financial and operational indicators include:

  • Export to over 120 countries
  • More than 300 employees globally
  • Facilities and affiliates in France, USA, China, India, Brazil, Netherlands, and South Africa
  • Robust investment in R&D, accounting for approximately 10% of annual revenue

Their continued expansion into emerging markets and human ART reflects long-term strategic growth and technological leadership.

Shipments and Usage Metrics

Trade data and internal metrics indicate:

  • Shipment of over 100 million AI consumables annually
  • Distribution partnerships with national livestock improvement boards, semen stations, and fertility clinics
  • Ongoing supply of cryogenic systems to global biobanks and genomics labs
  • High repeat order rate from veterinary practices and AI centers due to product reliability and innovation

IMV Technologies supports thousands of AI procedures every day worldwide, contributing to livestock productivity and reproductive health.

Target Market

IMV Technologies serves a wide range of sectors:

  • Livestock producers and breeders
  • AI centers and semen collection stations
  • Veterinary clinics and animal hospitals
  • Universities and research laboratories
  • Human fertility clinics and IVF centers
  • Conservation programs and biobanks

Their products are trusted by both commercial producers and scientific institutions, thanks to their consistent quality and scientific validation.

Capabilities

  • In-house R&D center with expertise in biotechnology, cryobiology, and imaging
  • ISO-certified manufacturing facilities in France and the USA
  • Custom product development for research and veterinary projects
  • On-site training and global technical support
  • Comprehensive product portfolio with over 1,000 SKUs across business lines

IMV Technologies also provides consultancy services for designing AI labs, embryo labs, and cryopreservation infrastructure.

Certifications and Compliance

IMV Technologies adheres to the highest global quality and safety standards:

  • ISO 9001 and ISO 13485 certifications
  • CE Marking for medical and veterinary devices
  • Compliance with EU, FDA, and IVD regulations
  • Cryo Bio System products conform to biological containment standards (HSS and Closed System Design)

Their focus on traceability and product sterility ensures compliance in both agricultural and medical contexts.

Customer Testimonials

  • "With IMV’s AI consumables, our conception rates have improved by 10%, and the quality is consistently reliable." – Director, National Cattle Breeding Center, India
  • "Cryo Bio System straws offer us peace of mind when storing genetic material from endangered species." – Cryobank Manager, Wildlife Conservation Program, South Africa

Major Achievements

  • Pioneers of the original plastic straw for semen packaging, now an industry standard
  • Inventors of CBS High Security™ straws, used in both animal and human reproductive science
  • Developed fully integrated semen processing stations, including lab automation
  • Long-term partners with government breeding programs and NGOs
  • Exhibitors at IPVS, EuroTier, VIV, and ESHRE, showcasing the latest in reproductive biotechnology

IMV Technologies continues to lead in advancing reproductive efficiency, genetic preservation, and biosecurity across agriculture and human health. With its foundation in science and commitment to innovation, the company remains a trusted global partner in reproductive success.